- JP-listed companies
- SANTEN PHARMACEUTICAL CO.,LTD.
- Financials
- Net income margin (%)
SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】
Market cap
¥600.3B
P/E ratio
17.1x
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 12.1 | +36.98% |
| Mar 31, 2024 | 8.8 | -264.70% |
| Mar 31, 2023 | -5.4 | -152.40% |
| Mar 31, 2022 | 10.2 | +273.58% |
| Mar 31, 2021 | 2.7 | -72.01% |
| Mar 31, 2020 | 9.8 | -28.39% |
| Mar 31, 2019 | 13.7 | -12.86% |
| Mar 31, 2018 | 15.7 | +35.28% |
| Mar 31, 2017 | 11.6 | -57.62% |
| Mar 31, 2016 | 27.3 | +84.10% |
| Mar 31, 2015 | 14.8 | +11.93% |
| Mar 31, 2014 | 13.3 | -4.40% |
| Mar 31, 2013 | 13.9 | -7.49% |
| Mar 31, 2012 | 15 |